Erudio Healtherudio.com
Clinical trial · no report yet · Phase 2/Phase 3
EXTEND-OP
A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)
- NCT06367972 ↗
- Recruiting
- M.D. Anderson Cancer Center
- Standard
We haven't built an HCP commentary report on EXTEND-OP (OligoProgressive Metastatic Disease) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on EXTEND-OP so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Channel | Indexed | |
|---|---|---|
| X threads | 13 | |
| YouTube | 3 | |
| Podcasts | 1 | |
| Bluesky threads | 1 |
The trial
ClinicalTrials.gov- Official title
- A Randomized Phase II Basket Trial EXTENDing Efficacy of Systemic Therapy With Local Consolidative Therapy for OligoProgressive Metastatic Disease (EXTEND-OP)
- Phase
- Phase 2/Phase 3
- Status
- Recruiting
- Conditions
- OligoProgressive Metastatic Disease
- Interventions
- Local Consolidation Therapy; Next-line Systemic Therapy
- Arms
- NLST Arm · Experimental
- LCT Arm · Experimental
- Enrollment
- 400 (estimated)
- Primary outcomes
- Safety and adverse events (AEs)
- Sponsor
- M.D. Anderson Cancer Center
- Start
- Jun 6, 2024
- Primary completion
- Oct 10, 2028 (estimated)
- Results posted
- No
- Registry record
- NCT06367972 · updated Jun 11, 2026